Dopaminergic mechanism of antidepressant action in depressed patients
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Affective Disorders
- Vol. 86 (1), 37-45
- https://doi.org/10.1016/j.jad.2004.12.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of acute or chronic administration of substituted benzamides in experimental models of depression in ratsEuropean Neuropsychopharmacology, 2000
- Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet StudyNeuroImage, 2000
- Antidepressant Action of Sulpiride. Results of a Placebo-Controlled Double-Blind TrialPharmacopsychiatry, 1999
- Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECTPsychiatry Research: Neuroimaging, 1999
- In VivoEvidence for the Involvement of Dopamine-D2Receptors in Striatum and Anterior Cingulate Gyrus in Major DepressionNeuroImage, 1997
- Clinical and Biochemical Effects of Catecholamine Depletion on Antidepressant-Induced Remission of DepressionArchives of General Psychiatry, 1996
- Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipraminePsychopharmacology, 1994
- Dopamine D2 receptors in depression measured with single photon emission computed tomographyBiological Psychiatry, 1994
- The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disordersInternational Clinical Psychopharmacology, 1993
- The use of analogue scales in rating subjective feelingsPsychology and Psychotherapy: Theory, Research and Practice, 1974